Altogether, these results suggested that dysregulation of Bcl-xL-mediated apoptosis played a critical role in the radioresistance of CRC cells, and targeting the TRAF4/Bcl-xL axis may be a promising therapeutic strategy to overcome the radioresistance of CRC cells. This evidence concerns the gene BCL2L1 and colorectal carcinoma.